MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Ramona Erber, Horia Sı̂rbu et al.|Cancers|2021Cited by 43
Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencingEvgeny A. Moskalev, Florian Haller, Robert Stöhr et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2013Cited by 34